Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2005

Feb 4, 2005

29777_dirs_2005-02-04_81b2bb88-df93-4dd5-a9cb-8a2f9bf18c64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-02

Reporting Person: DE LASA JOSE M (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-02-02 Common shares without par value M 2875 $34.7727 Acquired 109804 Direct
2005-02-02 Common shares without par value F 2194 $45.55 Disposed 107610 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-02-02 Option (right to buy) $34.7727 M 2875 Disposed 2008-02-12 common shares (2875) Direct
2005-02-02 Option (right to buy) $45.55 A 2194 Acquired 2008-02-12 common shares (2194) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 2301 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 2, 2005.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.